Found: 34
Select item for more details and to access through your institution.
Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 3, p. 200, doi. 10.3390/cells8030200
- By:
- Publication type:
- Article
Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 11, p. 2344, doi. 10.1002/ijc.22554
- By:
- Publication type:
- Article
Immune enhancement of nitroreductase-induced cytotoxicity: Studies using a bicistronic adenovirus vector.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 1, p. 104, doi. 10.1002/ijc.10916
- By:
- Publication type:
- Article
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.
- Published in:
- International Journal of Cancer, 2000, v. 86, n. 6, p. 848, doi. 10.1002/(SICI)1097-0215(20000615)86:6<848::AID-IJC14>3.0.CO;2-B
- By:
- Publication type:
- Article
RIPK3 promotes adenovirus type 5 activity.
- Published in:
- Cell Death & Disease, 2017, v. 8, n. 12, p. 1, doi. 10.1038/s41419-017-0110-8
- By:
- Publication type:
- Article
Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer.
- Published in:
- FASEB Journal, 2013, v. 27, n. 10, p. 4244, doi. 10.1096/fj.13-230441
- By:
- Publication type:
- Article
Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2074, doi. 10.1038/mt.2013.195
- By:
- Publication type:
- Article
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14206, doi. 10.1038/ncomms14206
- By:
- Publication type:
- Article
The Emerging Role of Interleukin 1β (IL-1β) in Cancer Cachexia.
- Published in:
- Inflammation, 2021, v. 44, n. 4, p. 1223, doi. 10.1007/s10753-021-01429-8
- By:
- Publication type:
- Article
Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
- Published in:
- Oncogene, 2003, v. 22, n. 23, p. 3539, doi. 10.1038/sj.onc.1206417
- By:
- Publication type:
- Article
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201911217
- By:
- Publication type:
- Article
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 6, p. 941, doi. 10.1038/s41416-023-02567-6
- By:
- Publication type:
- Article
Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In Vivo.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 9, p. 1676, doi. 10.1038/mt.2012.116
- By:
- Publication type:
- Article
Inhibition of the Inflammatory Cytokine TNF-α Increases Adenovirus Activity in Ovarian Cancer via Modulation of cIAP1/2 Expression.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 3, p. 490, doi. 10.1038/mt.2010.247
- By:
- Publication type:
- Article
Clear Cell Carcinoma of Ovary and Uterus.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 6, p. 566, doi. 10.1007/s11912-013-0346-0
- By:
- Publication type:
- Article
Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 4, p. 791, doi. 10.1016/j.molonc.2014.12.007
- By:
- Publication type:
- Article
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60149-5
- By:
- Publication type:
- Article
The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1264785
- By:
- Publication type:
- Article
The genomic trajectory of ovarian high‐grade serous carcinoma can be observed in STIC lesions.
- Published in:
- Journal of Pathology, 2024, v. 264, n. 1, p. 42, doi. 10.1002/path.6322
- By:
- Publication type:
- Article
Targeting DNA repair: the genome as a potential biomarker.
- Published in:
- Journal of Pathology, 2018, v. 244, n. 5, p. 586, doi. 10.1002/path.5025
- By:
- Publication type:
- Article
The peritoneal tumour microenvironment of high-grade serous ovarian cancer.
- Published in:
- Journal of Pathology, 2012, v. 227, n. 2, p. 136, doi. 10.1002/path.4002
- By:
- Publication type:
- Article
Rethinking ovarian cancer: recommendations for improving outcomes.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Practical guidance for the management of side effects during rucaparib therapy in a multidisciplinary UK setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920921980
- By:
- Publication type:
- Article
Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 7, p. 1377, doi. 10.1007/s00259-009-1379-3
- By:
- Publication type:
- Article
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 337, doi. 10.3390/cancers15020337
- By:
- Publication type:
- Article
Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2708, doi. 10.3390/cancers14112708
- By:
- Publication type:
- Article
Oncolytic virus‐induced cell death and immunity: a match made in heaven?
- Published in:
- Journal of Leukocyte Biology, 2017, v. 102, n. 3, p. 631, doi. 10.1189/jlb.5RU0117-040R
- By:
- Publication type:
- Article
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 12, p. 2762, doi. 10.1002/ijc.25202
- By:
- Publication type:
- Article
Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 8, p. 1450, doi. 10.3390/v13081450
- By:
- Publication type:
- Article
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 10, p. 2290, doi. 10.3390/v2102290
- By:
- Publication type:
- Article
PTEN deficiency exposes a requirement for an ARF GTPase module for integrin‐dependent invasion in ovarian cancer.
- Published in:
- EMBO Journal, 2023, v. 42, n. 18, p. 1, doi. 10.15252/embj.2023113987
- By:
- Publication type:
- Article
p21 promotes oncolytic adenoviral activity inovarian cancer and is a potential biomarker.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 175, doi. 10.1186/1476-4598-9-175
- By:
- Publication type:
- Article
CD40 ligand induced cytotoxicity in carcinomacells is enhanced by inhibition ofmetalloproteinase cleavage and delivery via aconditionally-replicating adenovirus.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 52, doi. 10.1186/1476-4598-9-52
- By:
- Publication type:
- Article